{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Cambridge",
      "state": "MA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "79083",
      "recalling_firm": "Millennium Pharmaceuticals Inc.",
      "address_1": "40 Landsdowne St",
      "address_2": "N/A",
      "postal_code": "02139-4234",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed nationwide. They estimate 4% of the product may be recovered.",
      "recall_number": "D-0425-2018",
      "product_description": "VELCADE (bortezomib) for injection, 3.5 mg/vial, Reconstitution Information, SUBCUTANEOUS INJECTION ONLY add 1.4 mL 0.9% Sodium Chloride to make 2.5 mg/ mL final concentration, INTRAVENOUS INJECTION ONLY add 3.5 mL Sodium Chloride to 1 mg/mL final concentration, Rx Only, Distributed by MILLENNIUM Pharmaceuticals, Inc., Cambridge, MA 02139-4234, NDC 63020-0049-01",
      "product_quantity": "154,372 vials",
      "reason_for_recall": "Defective Container: Confirmed reports of loose vial crimps.",
      "recall_initiation_date": "20180130",
      "center_classification_date": "20180214",
      "termination_date": "20181212",
      "report_date": "20180214",
      "code_info": "Lot Numbers # 224161, 224546 and 224547; Exp. 12/19"
    }
  ]
}